Podcasts about medtech conference

Medical Alley is a powerhouse in global healthcare innovation, connecting startups and Fortune 100 companies to transform healthcare solutions. Headquartered in Minnesota, it's one of the world's largest medtech clusters.At the 2024 MedTech Conference in Canada, MTPConnect and Medical Alley renewed an MOU to strengthen collaboration and support for Australian medtech companies looking to expand internationally.Now, Medical Alley is launching a game-changing online training program, Medical Alley Academy, designed to help innovators move into the US market - a great opportunity for Australian companies to tap into.Joining Caroline Duell to talk about this exciting initiative are Medical Alley CEO Roberta (Bobbie) Dresson and MTPConnect CEO Stuart Dignam.What's in this episode?·       How Medical Alley is shaping the future of medtech·       The changing trends and challenges in the US medtech ecosystem·       All about Medical Alley's new online Academy training ·       Key opportunities for Australian medtech companies to expand to the U.S.Tune in for expert insights and actionable advice for taking your medtech innovation global!

As thousands in the medical technology sector headed to Toronto, Canada for The MedTech 2024 Conference, MTPConnect was making sure that the 18 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections with a stopover in the medtech hub of Minnesota, before hitting Toronto.In this podcast special from North America, our MTPConnect CEO Stuart Dignam caught up with Kylle Jordan from Destination Medical Centre at the Mayo Clinic campus in Rochester Minnesota ahead of the Medtech conference to find out more about the 20-year initiative underway to expand the hospital precinct as a global medical care destination.Then it was on to the three-day MedTech Conference. MTPConnect signed an MoU with Medical Alley and Stuart talks with their new president and CEO Roberta Dressen about working together to foster global partnerships in health technology.Stuart was on the ground at the Australian Pavilion and caught up with some of Australia's medtech movers and shakers including iYarn's Founder and CEO Lockie Cooke, University of Melbourne's Principal Research Fellow, Optometry and Vision Sciences, A/Prof Lauren Ayton, Materia Health's Founder, Dr Emily Zhen as well as the delegation's major supporter, Global Victoria's Carolin McCaffrey.   The Team Australia delegation was supported by our major sponsor the Victorian Government, through Global Victoria and Invest Victoria, as well as support from NSW Health and AusBiotech.

EY recently published their 18th annual Pulse of the MedTech Industry report, highlighting how—despite steadily rising profits year-over-year—devicemakers large and small are still being squeezed by the cost of doing business and waning investor enthusiasm.   During AdvaMed's MedTech Conference this month in Toronto, John Babbitt, partner on the life sciences team at EY, chatted with Fierce Medtech's Conor Hale about the team's findings and shared what he heard from other executive attendees on the pace of M&A, venture capital funding and recent IPOs.   Babbitt also discussed how the industry is expanding over-the-counter, to stock shelves with consumer-focused products—as well as how a record number of AI approvals from the FDA may be counted on to help address the ever-growing demand for healthcare, amid provider burnout and staff shortages.  To learn more about the topics in this episode:  Ceribell CEO Jane Chao explains why now was the time for its upsized IPO Stryker strikes again, acquiring brain surgery device maker Nico How will regulators adapt to adaptive AI? Medtech VC investment held steady in Q2 with $3.3B of deal value: PitchBook EY's Pulse of the MedTech Industry report 2024 See omnystudio.com/listener for privacy information.

The 2nd edition of the Transforming African MedTech Conference took place from 28 – 30 August 2024 in Nairobi, Kenya. At the sidelines of the conference, I spoke with several delegates who shared their highlights. They include: Winnie Kibiru, MedTech Lead, Villgro Africa. She is one of the brains behind the conference and she talked about the event's vision and goals. Vivian Arinaitwe, CEO and co-founder, Che Innovations. Her innovation, the Neonest, was one of several amazing medtech devices on exhibition. Hellen Gitonga, Regulatory Affairs Specialist for Africa at Philips Health Systems. She spoke about her experiences as a judge during the pitch competition for startups. Sewu-Steve Tawia, Co-founder and Managing Partner, Jaza Rift Ventures. They are one of the conference's conveners and are a major investor in Africa's medtech sector. Eddine Sarroukh, Innovation Lead at Phillips Foundation. He moderated a powerful panel discussion on addressing barriers to medtech innovation in Africa. Prof Ndirangu Kioni, former Vice Chancellor, Dedan Kimathi University of Technology. He spoke about academia's catalytic role in medtech innovation. Kimani Chege, a freelance journalist who gave the media's perspective of the event. Rob Beyer, Co-founder and Executive Chair, Villgro Africa. He wrapped up the episode by addressing the ‘so what' and ‘what next' of the conference. For more information about the Transforming African Medtech Conference, visit: https://www.africanmedtech.com/ MedxTek Africa is produced and hosted by ⁠⁠⁠⁠⁠Dr. Sam Oti⁠⁠⁠⁠⁠, and co-edited by ⁠⁠⁠⁠⁠Veronica Ojiambo⁠⁠⁠⁠⁠. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

As thousands in the medical technology sector headed to Anaheim, California for The MedTech 2023 Conference, MTPConnect was making sure that the 20 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections. In this podcast special from Los Angeles, our CEO Stuart Dignam was with the delegation when he caught up with US medtech movers and shakers to gain some insights into how to crack the world's largest medical technology market. Tune in to hear from Edwards Lifesciences' Dr Farzad Azimpour, Scalehealth's Chris Spearman, BioscienceLA's Dave Whelan, Peptilogics' Dr Nick Pachuda and Medical Alley's Kylle Jordan. Stuart also connected with two Australians now based in the US – BiVACOR's Founder and CTO Dr Daniel Timms who is developing a total artificial heart at the company's manufacturing and R&D site in California, and Stryker's Vice President and General Manager ENT Business Unit, Kate Stewart who is now based in Minnesota. They shared their tips on doing business in the US, leveraging technology and scaling up innovations for global markets.The Team Australia delegation was backed by Austrade and our partners, Global Victoria, Trade and Investment Queensland, Invest and Trade WA. 

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, October 12, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Novo Nordisk has announced that it acquired all shares of drug delivery device maker Biocorp. Fast Five host Danielle Kirsh and guest cohost Jim Hammerand discuss the deal, including when the acquisition talks began. Ambu named its new chief financial officer for 2024. Find out who is taking over and what some of their career history is that supports this appointment.  The FDA has approved a next-gen intrathecal drug delivery system from Medtronic. Kirsh and Hammerand talk about the technology and what sets it apart from previous iterations of the device.  Medtech Innovator announced the 2023 Grand Prize winner at AdvaMed's Medtech Conference in Anaheim. Hear who the winner is and what their technology does in today's episode.  Boston Scientific won an expanded indication for its spinal cord stimulation system. The Fast Five hosts talk about the technology, some of the features and the optimism that executives have after this approve. Bonus: Sean Whooley brings his insights from the AdvaMed Medtech Conference. His biggest takeaway from Day 2 is about building innovative business models and disruptive technologies, as well as what big companies are thinking about mergers and acquisitions. Tune in to hear what he had to say and check out the rest of his coverage on MassDevice here.

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, October 11, 2023. Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast. Hyperfine received FDA 510(k) clearance for its artificial intelligence software for improve image quality on its Swoop portable MRI system. Fast Five host Danielle Kirsh and guest host Jim Hammerand discuss the latest software development and how it updates that MRI system. Medtronic is warning on some of its previous software on some MiniMed 780G devices in Germany. Find out what the issue is and how patients could be affected. The FDA wants more testing from Philips in the ongoing recall of its Respironics respiratory devices. Kirsh and Hammerand talk about why the FDA wants more testing from Philips and what Philips plans to do to address that. Reuters is reporting that Boston Scientific is opening its first factory in China. Hear what the report said and why the company is making a major play in China. Haemonetics is strengthening its cardiology device portfolio with the acquisition of OpSens. Kirsh gives the financial details behind the deal and how OpSens' devices will improve Haemonetics' existing portfolio. BONUS: Sean Whooley is on the ground at AdvaMed's Medtech Conference in Anaheim, California this week and he gives us one major takeaway from the talks he has sat in on so far. Hear how digital health is hitting a boom.

Caroll Neubauer has a distinguished career in medtech, as the former long-time leader of B. Braun Medical Inc., now an adviser at Water Street Healthcare Partners, and co-chairman of The MedTech Conference Steering Committee. Caroll joined me on the Medtech POV podcast and previewed The MedTech Conference, Oct. 9-11, in Anaheim, California.

MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia's outstanding innovative medical technologies and capabilities to the world's largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking events, the mission was supported by Austrade and state partners Global Victoria, Invest & Trade Western Australia, NSW Health, Trade and Investment Queensland and the Government of South Australia.In the second of this two-part special, MTPConnect's CEO Stuart Dignam chats to Medical Alley Association's Vice President of Intelligence Frank Jaskulke ahead of signing an MoU. The agreement will build on an already strong relationship and help support Australian medtech companies and start-ups seeking access to the US Market. Stuart also catches up with some Team Australia delegates making connections in Boston, including, CSIRO's Dr Dharmini Robertson, Singular Health's Martina Mariano, IDE Group's Leah Trend, Crow Clinical's Julie Hicks and Julie Von Grom, WearOptimo's Nicolas Gikakis, Virtetic's Dr Ricardo Garcia Rosas, Customa's Dr Guan Tay, Ferranova's Stewart Bartlett, Datawre's Dr Stephanie Chausis and Mobius Medical' s Stefan Czyniewski.

MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia's outstanding innovative medical technologies and capabilities to the world's largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking events, the mission was supported by Austrade and state partners Global Victoria, Invest & Trade Western Australia, NSW Health, Trade and Investment Queensland and the Government of South Australia.In this first episode of our two-part special, MTPConnect CEO Stuart Dignam chats to Rachel Rath, Director of the BARDA Alliance for Johnson & Johnson Innovation after Team Australia toured the JLABS life science and healthcare incubator, the newest in J&Js worldwide stable of facilities. He also catches up with Australian cardiologist, Professor Ian Meredith, Executive Vice President and Global Chief Medical Officer from Boston Scientific, Caroline McCaffrey, Director of Investment & Trade at Global Vic and some Team Australia delegates including, iishield's Dr Jeremy Kwarcinski, Hydrix's Peter Lewis, Design and Industry's Adam Donath, Cortical Dynamics' Ashley Zimpel and Jay-Nik's Clare Brown.

David Lim talks with Ruth Reader about the biggest takeaways from MedTech, an annual conference held by the medical device industry. Plus, researcher Eric Bressman discusses a new study that found that sending patients automated text messages to check on them after they've left the hospital can reduce their chances of readmission or a visit to the emergency room.

In this week's podcast, reporters discuss the high points of the recent AdvaMed MedTech Conference. Ferdous Al-Faruque goes in-depth on FDA comments about user fees, while Brian Bossetta discusses varying points of view on Medicare coverage of breakthrough devices – including the crucial role of real-world evidence.

Device Week, 9 October 2020 – Insights From NASS And The Medtech Conference by Informa

To mark our involvement in the Virtual Medtech Conference 2020 in Toronto,  we hosted a special webinar with Austrade, for US and Canadian medical device companies who may benefit from running clinical trials in Australia. The session explored ‘Australia as a medical device trial destination: Maintain momentum in your clinical development program', and focused on first-in-human / early phase cardiovascular medical device trials.  Discussions cover the clinical trials landscape in Australia and the impact of COVID-19 on maintaining research momentum, the opportunities for international collaboration and a German company's firsthand experience as a multinational medical device company running clinical trial programs in Australia.  A special thanks to our stellar panel:Hon. Peter McGauran – Australia's Consul General and Senior Trade & Investment Commissioner, Austrade HoustonDr Dan Grant – Managing Director & CEO MTPConnectProf John Kovacic – Executive Director Victor Chang Cardiac Research InstituteProf Gemma Figtree – President Australian Cardiovascular Alliance Mr Falko Thiele – Director Clinical & Regulatory Affairs BIOTRONIK Australia (HQ Germany)

The MTPConnect podcast team bring you more on the ground conversations with international delegates and our Australian companies at the 2019 MedTech Conference in Boston. Check out Dr Kath Giles and the OncoRes Medical team and Macuject's Devinder Chauhan. JP Morgan's Mike Gietl, Evidence Matters' Leslie Wise, Nine Point Medical's Eman Namati and Austrade USA's Elizabeth Thomas also share their experiences, observations and advice on getting Australian medtech into the US market.

The 2019 MedTech Conference is underway and the MTPConnect team is on the ground in Boston to bring you exclusive chats with Australian delegates like Bionics Institute's CEO Robert Klupacs and international participants like Finland's Marcello van Rossum from the Helsinki Business Hub. 

The 2019 MedTech Conference is fast approaching and Melbourne-based Hydrix will be there are part of the Aussie delegation. We chat to the company's Director of Business Development Richard Stephens about his plans and expectations for this years' conference. 

The Bionics Institute has signed-up to join MTPConnect's delegation to the 2019 MedTech Conference in Boston in September -- and you can too. CEO Robert Klupacs chats with us about the benefits of being part of the Australian delegation. He also shares his insights on how to take advantage of the conference and strategies for building connections and opening-up new market opportunities. 

Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before the financial executive found his first job in Medtech. In this interview conducted at the Medtech Conference in Minneapolis, Lobo reveals that while he first was reluctant to take that Medtech job, he’s now grateful to have found a home. “If you’ve only been in Medtech, you do not understand how lucky you are to be in this industry.” Lobo shares insights on how he built a career that positioned him to lead one of Medtech’s giant. He also explains why under his watch Stryker grew to become a “serial acquirer” of that has spent $14 billion to acquire 55 companies during his tenure as CEO.

Thank you for your support of the MedtechTalk Podcast. We hope to see you at the Medtech Conference next week. We’ll be posting compelling interviews with Medtech’s leaders immediately after the conference.

Anyone who has swapped emails with Scott Huennekens has seen the Go Go Go signature at the bottom. They’re three little words, but they say so much about the special brand of enthusiasm Huennekens brings to leading companies like Digirad, Volcano, and most recently, Verb, the partnership between Google and Johnson & Johnson. In this podcast, Huennekens explains what he learned about maintaining momentum in Medtech. When is grit misplaced? When is hopping on a plane to Europe with no plan in hand a good idea? Huennekens will bring his insights to the Medtech Conference on May 29–30.

Spoiler Alert: I missed a huge part of Merit Medical CEO Fred Lampropoulos’ life story when I did my research. I won’t say what it was, but you’ll hear it at the end. I’d fire my researcher if I had one, but instead I’ll just throw myself at the mercy of the Medtech Talk Podcast community. The good news, however, is that the thing that I missed – which would have removed Fred from Merit – didn’t happen, so he’s been able to build a multibillion-dollar Medtech that’s scooping up smaller players in the space. Fred’s an engaging fellow and we covered a lot of ground, including: What is Merit looking for in an acquisition target? How does Lampropoulos manage a publicly traded Medtech? Why doesn’t Utah have more Medtech start-ups? And finally, what does Lampropoulous have to say about the spate of bad press Medtech has been getting lately?At the Medtech Conference on May 29–30 hear from CEOs who have led their companies through an IPO and learn what they must do to thrive on the public markets, in the panel – How to Build for an IPO … and Beyond. Panelists include:Joe Army, President & CEO - VapothermTim Herbert, President & CEO - Inspire Medical SystemsGerald R. Mattys, CEO - Tactile Medical

Earlier this month, Silicon Valley Bank released its Trends in Healthcare Investments and Exits 2019, the latest of the bank’s annual reports on the state of healthcare investing. In this podcast we talk with Report Guru (and Managing Director) Jonathan Norris about the top takeaways including:What’s the emerging hot spot for Device Start-Ups?What VCs are making Series A deals?Are Angels and Crowdfunding groups making an impact?How busy are Corporates?What’s a Big Exit? And why are they on the rise?You can download the report yourself here.Join us at the Medtech Conference to hear Norris’ update on Medtech Funding

Miromatrix straddles the line between biotech and medtech. The start-up is developing a line of “ghost organs” that can be used in humans. The technology is moving fast, and Ross hopes to have clinical trials up and running by the end of 2020. The future is here. Also, I’ll announce a keynote speaker for the May 30 Medtech Conference.

On this week's podcast, we discussed some key takeaways from this week's MedTech Conference, including a significant focus on the need for device companies to become data companies and establish new ways to directly engage patients to compete in the new digital reality. Also, some FDA digital health updates, and discussion of the China tariffs. For more information about Medtech Insight and to sign up for a free trial go to bit.ly/2w7LnlR. Medtech Insight articles addressing topics discussed in this episode: The Medtech Conference: Industry Is Falling Short In Digital Investments https://bit.ly/2OpfP4M Jeff Shuren Talks Breakthrough Bonanza, TPLC And Innovating Safety https://bit.ly/2Qa2iLx AdvaMed Chair Nadim Yared Talks Challenges, Priorities https://bit.ly/2IpWZoy

We were hoping to capture some real-world wisdom by putting three CEOs –Bill Facteau of Earlens, Bob Paulson of NxThera and John Stevens of HeartFlow –on a panel to share reimbursement war stories. Many of those attending the May 31st Medtech Conference think we got our wish.

CEOs often are assigned skill sets that define their stage of specialty: start-up CEOs, commercial CEOs, etc. Two of our guests at the Medtech Conference in Minneapolis defied those definitions by taking start-ups through commercial launches and onto the public markets. In these interviews, Tim Herbert of Inspire Medical and Adam Elsesser of Penumbra talk about the challenges of leading a company from Day 1 to IPO.

A brief review of the 2018 Medtech conference in Minneapolis

Join us on Thursday at the Medtech Conference in Minneapolis to hear from Congressman Erik Paulsen. A longtime proponent of the Medtech industry, Rep. Paulsen most recently co-authored a letter asking the Trump administration to remove medical technology products from a list of Chinese imports subject to protective tariffs. The five-term Congressman also has fought against the Medical Device Tax. The Medtech Conference co-chairs and advisory board also are pleased to honor Dave Amerson, CEO of NeoTract, as the recipient of this year’s Dealmaker of the Year Award. The award recognizes Amerson's leadership of the urology start-up as it established its UroLift System as a critical treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Sales of UroLift were surging when Teleflex agreed to acquire the company, paying $725 million up front with the promise of another $375 million in milestone payments over the next two years. In an interview, Justin Klein, general partner of NEA, and Amerson will discuss: The steps Neotract took to adopt a winning culture? What strategies helped the company secure support from payers, providers? How the deal with Teleflex came to be? What's next for Teleflex in Urology? Join us on May 31st to explore this singular successful story and to better understand our entire Medtech sector.

David Van Sickle, CEO & Co-Founder of Propeller Health, brings his public health background to health tech start-up Propeller Health. The company has created a line of sensors that work in conjunction with inhalers and spirometers to measure medication intake and breathing capacity of people with asthma. The start-up has undertaken some bold projects with entire cities including Louisville to demonstrate how tools such as these can benefit communities. In this podcast Van Sickle discusses the company's unique origins, its technology and a small hiccup involving the company's former name. Van Sickle will be speaking on an innovative panel at the May 31 Medtech Conference in Minneapolis.

David Van Sickle, CEO & Co-Founder of Propeller Health, brings his public health background to health tech start-up Propeller Health. The company has created a line of sensors that work in conjunction with inhalers and spirometers to measure medication intake and breathing capacity of people with asthma. The start-up has undertaken some bold projects with entire cities including Louisville to demonstrate how tools such as these can benefit communities. In this podcast Van Sickle discusses the company's unique origins, its technology and a small hiccup involving the company's former name. Van Sickle will be speaking on an innovative panel at the May 31 Medtech Conference in Minneapolis.

Hard to find anyone working harder than Jonathan Norris to help us see the forest for the trees. Jon is a fixture at many conferences including – thankfully – the upcoming Medtech Conference on May 31. But we wanted to get to his insights early. In this Medtech Talk Podcast, Jon and I discuss his report, “Trends in Healthcare Investments and Exits 2018.” Overview: Jon shares some positive views for Medtech. Good to hear. Surprises: I didn’t know Jon’s initial career choice. Regrets: I didn’t get to ask how his pitching arm is doing. Jon still plays ball on a regular basis. Enjoy the podcast!

In this edition of Device Week, Medtech Insight’s Tina Tan chats to Marion Webb about AdvaMed’s annual Medtech Conference held at the end of September and which were the most interesting startups showcased at the meeting. She also speaks to Reed Miller to discuss the more notable M&A deals that have happened in this recent surge of acquisition activity. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: Medtronic Stands To Be Biggest Beneficiary Of J&J's Exit From Insulin Pump Market http://bit.ly/2zfE2zX From AI-Based IVDs To Precision Drug Dosing: Medtech Conference 2017 Gives Insight Into Tomorrow's Technologies http://bit.ly/2kFpkz4

On this week’s podcast, we discuss big announcements from FDA at AdvaMed’s recent MedTech Conference on digital health policy and an upcoming device-center reorganization, as well as the recent resignation of Tom Price as US HHS secretary. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: 'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means: http://bit.ly/2fUcyuV Gottlieb At The Medtech Conference: US FDA Commissioner Talks About CDRH Innovation, Puerto Rico, LDTs And More: http://bit.ly/2hP0Fae 'Super Office' To The Rescue: FDA's Device Center Is About To Undergo A 'Total Product Life Cycle' Makeover: http://bit.ly/2yKvgIY HHS Secretary Tom Price Resigns Over Free-Flights Flap: http://bit.ly/2fPuP98

CDRH Director Jeff Shuren talked to Medtech Insight at this year’s Medtech Conference about the planned “super office” at the agency that would take over the roles of a number of critical offices and upend the center’s bureaucratic structure.

FDA Commissioner Scott Gottlieb announced the agency had selected Apple, Verily, Samsung and Fitbit among the nine companies that will participate in its Pre-Certification Program at this years The MedTech Conference. The top FDA official leading the effort Bakul Patel spoke to Medtech Insight about their selection process and what’s next.

Speaking to reporters at AdvaMed's annual 2017 Medtech Conference in San Jose, Scott Whitaker and Nadim Yared, president and chairman of the medical device lobby group, talked about their ongoing medical device repeal efforts and possible acceptance of a temporary moratorium instead of a full repeal.

Jonathan Norris of Silicon Valley Bank follows up his recent Medtech Conference presentation with insights on healthcare exits, the latest M&A chatter, the resurgence of biopharma deals, which type of Medtech start-up gets the most action, and the drastic decline in Series A device deals.

What steps did Boston Scientific – under Mahoney’s leadership – take to unlock such significant growth? In an interview at the Medtech Conference, Mahoney – interviewed by Kevin Hykes, CEO of Metavention - laid out some of the meaningful changes Boston Scientific made.

Medtech Conference Co-Chair Kevin Hykes, who is finishing up his two-year tour of duty as a conference co-commander, reviews the agenda for next week’s Conference.

Steve Clark, senior vice president at Optum Life Sciences, says healthcare rests in the “nascent” stages of questioning effectiveness of medical tech. Successful start-ups will find the right answers to those questions.

Jerry Harrison, rock star turned investor, joined with former Wall Streeter Brian A. Smith to create Red Crow to build a platform for healthcare start-ups to tap the “crowd” as a new source of capital.

Medtech Conference co-chair Stacy Enxing Seng, after succeeding at both start-ups and corporates, shares her enthusiasm for her new role as venture partner at Lightstone Ventures.

Medtech Conference co-chair Kevin Hykes revisits his days at Visiogen and Cameron Health, explaining how those successful outcomes help guide his hand on Metavention’s tiller.

Last month, a surgeon performed ophthalmology’s first robot-assisted surgery – a membrane peel. Marc de Smet, chief medical officer of Preceyes, a Dutch start-up, shares the company’s history and plans for the future.

Backed by nearly $30 million from the Department of Defense, BrainScope created a device to make concussion diagnosis more certain. Hear what’s next for the Medtech start-up.

Ashley McEvoy, Company Group Chairman, Johnson & Johnson Vision Care and Johnson & Johnson Diabetes Care Companies, says the new force could pursue M&A in future expansion. Hear the details of the deal.

Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.

Chen Yu, MD, managing director of Vivo Capital, has built a career finding the right deals at the right time in the US and China. Hear what US companies can do to take advantage of potential Pan Pacific opportunities.

Data guru Jon Norris, managing director at Silicon Valley Bank, reviews his first-half numbers for ophthalmology and life sciences. Norris’ first-half numbers for Medtech start-ups show some surprising sources of strength for the sector.

ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.

Meet the newest Master of the Industry. Jim Mazzo, who has led divisions, spin-outs, and start-ups, now leads what looks to be a new leader in ophthalmology. Hear how Mazzo views this new opportunity for Zeiss and himself.

Over two decades ago, Mark Humayun – who will co-chair our upcoming OIS@ASRS meeting in San Francisco – helped launch a “moonshot” that would eventually restore vision for retinitis pigmentosa patients. In this podcast we discuss what drives him and what’s next for ophthalmology.

Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how the company will sell going forward.

Eric Timko, the former CEO of Blue Belt, shares how the company used MAKO’s wake to build a market for its surgical robot and sell the business to Smith & Nephew. Timko explains the company’s fast-follower strategy and shares what he’s looking to do next.

The board at Ulthera, an aesthetics device company, faced an attractive dilemma. Take the company public? Or accept a lucrative buyout? Hear from the CEO how the company’s culture and approach led to that favorable outcome.

Gilde Healthcare Partner Geoff Pardo shares how the firm will invest its new $250 million in health care companies, including Medtech.

Julie Allen, principal of Allen Partners, shares insights on how Medtech executives must work to find the right fit and how companies can build their best team.

The experienced CEOs on this panel have authored some of the greatest stories in Medtech. In this discussion, they delve into their approaches to managing start-ups to multi-million – or billion – dollar acquisitions or IPOs. How do they accurately assess a struggling company and direct a team to turn weakness into strength?

Medtronic executive VP Geoff Martha talks with OISTV about how the Medtech giant views robotics, payers, and where health care transformation is the most difficult. The podcast also includes a clip from his keynote interview at the Medtech Conference.

Abbott’s move to acquire St. Jude demonstrates how Medtronic’s moves toward “Total Solutions” may change the game in Medtech. We’re going to tackle that topic at the June 1 Medtech Conference. Our conference co-chairs discuss that piece of our upcoming agenda as well as our focus on robotics.